Continuous administration of enteral lipid-and protein-rich nutrition limits inflammation in a human endotoxemia model

Critical Care Medicine

Volumn 41, Issue 5, 2013, Pages 1258-1265

  Lubbers, Tim ^a   Kox, Matthijs ^b   De Haan, Jacco Juri ^a   Greve, Jan Willem ^c   Pompe, Jan C ^b   Ramakers, Bart P ^b   Pickkers, Peter ^b   Buurman, Wim A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Zuyderland Medical Centre   (Netherlands)

Author keywords

anti inflammatory reflex; endotoxin; enteral nutrition; enterocyte damage; systemic inflammation

Indexed keywords

CHOLECYSTOKININ; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOTOXEMIA; ENTERIC FEEDING; HUMAN; HUMAN EXPERIMENT; LIPID DIET; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

ADULT; DIETARY PROTEINS; DOUBLE-BLIND METHOD; ENDOTOXEMIA; ENTERAL NUTRITION; HUMANS; INFLAMMATION; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; INTUBATION, GASTROINTESTINAL; LIPIDS; MALE; MODELS, BIOLOGICAL; POLYSACCHARIDES; REFERENCE VALUES; RISK ASSESSMENT; YOUNG ADULT;

EID: 84876666773     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31827c0a17     Document Type: Article

References (47)

1. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nat Med 2003; 9:517-524
2. Yende S, D'Angelo G, Kellum JA, et al; GenIMS Investigators: Infam-matory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008; 177:1242-1247
3. Osuchowski MF, Welch K, Siddiqui J, et al: Circulating cytokine/inhib-itor profles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006; 177:1967-1974
4. Rice TW, Wheeler AP, Bernard GR, et al: A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 2010; 38:1685-1694
5. Marshall JC, Charbonney E, Gonzalez PD: The immune system in critical illness. Clin Chest Med 2008; 29:605-616, vii
6. Cinel I, Opal SM: Molecular biology of infammation and sepsis: A primer. Crit Care Med 2009; 37:291-304
7. Parrish WR, Gallowitsch-Puerta M, Czura CJ, et al: Experimental therapeutic strategies for severe sepsis: Mediators and mechanisms. Ann N Y Acad Sci 2008; 1144:210-236
8. Lubbers T, de Haan JJ, Luyer MD, et al: Cholecystokinin/cholecysto-kinin- 1 receptor-mediated peripheral activation of the afferent vagus by enteral nutrients attenuates infammation in rats. Ann Surg 2010; 252:376-382
9. de Haan JJ, Lubbers T, Hadfoune M, et al: Postshock intervention with high-lipid enteral nutrition reduces infammation and tissue damage. Ann Surg 2008; 248:842-848
10. van der Zanden E P, Snoek SA, Heinsbroek SE, et al: Vagus nerve activity augments intestinal macrophage phagocytosis via nico-tinic acetylcholine receptor alpha4beta2. Gastroenterology 2009; 137:1029-1039, 1039.e1
11. Wang H, Yu M, Ochani M, et al: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of infammation. Nature 2003; 421:384-388
12. Karhunen LJ, Juvonen KR, Huotari A, et al: Effect of protein, fat, carbohydrate and fbre on gastrointestinal peptide release in humans. Regul Pept 2008; 149:70-78
13. Lowry SF: Human endotoxemia: A model for mechanistic insight and therapeutic targeting. Shock 2005; 24(Suppl 1):94-100
14. Pickkers P, Dorresteijn MJ, Bouw M P, et al: In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia. Circulation 2006; 114:414-421
15. van Eijk LT, Dorresteijn MJ, Smits P, et al: Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med 2007; 35:1464-1469
16. Pilichiewicz AN, Papadopoulos P, Brennan IM, et al: Load-dependent effects of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 2007; 293:R2170-R2178
17. Derikx J P, van Waardenburg DA, Thuijls G, et al: New insight in loss of gut barrier during major non-abdominal surgery. PLoS One 2008; 3:e3954
18. van Wijck K, Lenaerts K, van Loon LJ, et al: Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. PLoS One 2011; 6:e22366
19. van Ginhoven TM, Mitchell JR, Verweij M, et al: The use of preop-erative nutritional interventions to protect against hepatic ischemia-reperfusion injury. Liver Transpl 2009; 15:1183-1191
20. Søreide E, Ljungqvist O: Modern preoperative fasting guidelines: A summary of the present recommendations and remaining questions. Best Pract Res Clin Anaesthesiol 2006; 20:483-491
21. Noblett SE, Watson DS, Huong H, et al: Pre-operative oral carbohydrate loading in colorectal surgery: A randomized controlled trial. Colorectal Dis 2006; 8:563-569
22. El Nakeeb A, Fikry A, El Metwally T, et al: Early oral feeding in patients undergoing elective colonic anastomosis. Int J Surg 2009; 7:206-209
23. Kreymann KG, Berger MM, Deutz NE, et al; DGEM (German Society for Nutritional Medicine); ESPEN (European Society for Parenteral and Enteral Nutrition): ESPEN guidelines on enteral nutrition: Intensive care. Clin Nutr 2006; 25:210-223
24. Wang PY, Caspi L, Lam CK, et al: Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 2008; 452:1012-1016
25. Chandra R, Liddle RA: Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 2007; 14:63-67
26. Lubbers T, De Haan JJ, Hadfoune M, et al: Lipid-enriched enteral nutrition controls the infammatory response in murine gram-negative sepsis. Crit Care Med 2010; 38:1996-2002
27. Lubbers T, Luyer MD, de Haan JJ, et al: Lipid-rich enteral nutrition reduces postoperative ileus in rats via activation of cholecystokinin-receptors. Ann Surg 2009; 249:481-487
28. Luyer MD, Greve JW, Hadfoune M, et al: Nutritional stimulation of cholecystokinin receptors inhibits infammation via the vagus nerve. J Exp Med 2005; 202:1023-1029
29. Flohé SB, Flohé S, Schade FU: Invited review: Deterioration of the immune system after trauma: Signals and cellular mechanisms. Innate Immun 2008; 14:333-344
30. Abraham E, Laterre P F, Garbino J, et al; Lenercept Study Group: Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1, 342 patients. Crit Care Med 2001; 29:503-510
31. Harbarth S, Holeckova K, Froidevaux C, et al; Geneva Sepsis Network: Diagnostic value of procalcitonin, interleukin-6, and interleu-kin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164:396-402
32. Hotchkiss RS, Coopersmith CM, McDunn JE, et al: The sepsis seesaw: Tilting toward immunosuppression. Nat Med 2009; 15:496-497
33. van der Poll T, van Deventer SJ, ten Cate H, et al: Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia. J Infect Dis 1994; 169:665-667
34. Gabay C, Smith M F, Eidlen D, et al: Interleukin 1 receptor antagonist (IL-1RA) is an acute-phase protein. J Clin Invest 1997; 99:2930-2940
35. van der Poll T, Coyle SM, Barbosa K, et al: Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97:713-719
36. Arzt E, Sauer J, Pollmächer T, et al: Glucocorticoids suppress interleu-kin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology 1994; 134:672-677
37. Howard M, Muchamuel T, Andrade S, et al: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993; 177:1205-1208
38. de Haan JJ, Lubbers T, Derikx JP, et al: Rapid development of intestinal cell damage following severe trauma: A prospective observational cohort study. Crit Care 2009; 13:R86
39. Derikx JP, Poeze M, van Bijnen AA, et al: Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock 2007; 28:544-548
40. Fink M P, Delude RL: Epithelial barrier dysfunction: A unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 2005; 21:177-196
41. de Haan JJ, Thuijls G, Lubbers T, et al: Protection against early intestinal compromise by lipid-rich enteral nutrition through cholecystokinin receptors. Crit Care Med 2010; 38:1592-1597
42. Pilichiewicz AN, Little TJ, Brennan IM, et al: Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 2006; 290:R668-R677
43. Reidelberger RD, Kalogeris TJ, Solomon TE: Plasma CCK levels after food intake and infusion of CCK analogues that inhibit feeding in dogs. Am J Physiol 1989; 256(5 Pt 2):R1148-R1154
44. Berthoud HR: Vagal and hormonal gut-brain communication: From satiation to satisfaction. Neurogastroenterol Motil 2008; 20(Suppl 1):64-72
45. Calder PC: n-3 polyunsaturated fatty acids, infammation, and infammatory diseases. Am J Clin Nutr 2006; 83(6 Suppl): 1505S-1519S
46. Vermeulen MA, van de Poll MC, Ligthart-Melis GC, et al: Specifc amino acids in the critically ill patient-exogenous glutamine/arginine: A common denominator? Crit Care Med 2007; 35(9 Suppl):S568-S576
47. Harris HW, Johnson JA, Wigmore SJ: Endogenous lipoproteins impact the response to endotoxin in humans. Crit Care Med 2002; 30:23-31